Reference number : 172-2024-2025-Q1-1016948, amendment number : 1, agreement type : C, recipient legal name : Eyam Vaccines and Immunotherapeutics Ltd., recipient country : CA, recipient province : BC, recipient city : New Westminster|New Westminster, recipient postal code : V3M 6B9, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : ICAP 2024 – International Co-Innovation Action Plan, agreement title french : PACI 2024 - Programme d’action de co-innovation internationale, agreement number : 1016948, agreement value : 50000.0, agreement start date : 2024-04-01, agreement end date : 2024-12-31, description english : This International Co-Innovation Action Program (ICAP) project will prepare the firm to enter into future international co-innovation work., description french : Ce projet du Programme d’action de co-innovation internationale (PACI) préparera l’entreprise à entreprendre de futurs travaux internationaux de co-innovation., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days., additional information french : Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de  61 jours., owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada